drug

Cognitive Therapy

as of 2026-07-01
Add to landscapeMonitor thisCompare thisAsk about this
at a glance
BEHAVIORAL
Pre-approval / investigational in the US
Developed by University of Pennsylvania
1 trials in the graph
Synthesized from structured facts only — each point cited above.

Mechanism & identity

Modality
BEHAVIORAL

Indications

Trials

1
Cognitive Therapy for Negative Symptoms and Functioning
NCT00350883Phase 2Completed

KOLs & investigators

2
Paul M Grant, PhD
Aaron T Beck, MD

Facts & assertions

0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
University of Pennsylvania
company
trial
Cognitive Therapy for Negative Symptoms and Functioning
PHASE2
trial
indication
Schizophrenia
indication
Schizophrenia
indication
Psychotic Disorders
indication
Schizoaffective Disorder
indication
KOL
Paul M Grant, PhD
KOL score —
person
Aaron T Beck, MD
KOL score —
person